Pharmaceutical Information |
Drug Name |
Technetium tc-99m medronate |
Drug ID |
BADD_D02129 |
Description |
Technetium (99mTc) medronic acid is a pharmaceutical product used in nuclear medicine imaging. It is composed of a technetium ion complexed with medronic acid, a type of bisphosphonate. Like other bisphosphonates used in the treatment of osteoporosis, medronic acid binds to the hydroxyapatite crystals within bone, and in this way localizes the drug to bone for delineation of areas of altered osteogenesis. Following intravenous injection, single photon emission computed tomography (SPECT) is performed to detect the gamma ray emmitted by the decay of Technetium-99m to Technetium-99. |
Indications and Usage |
Technetium Tc 99m Medronate is indicated for use as a bone imaging agent to delineate areas of altered osteogenesis. |
Marketing Status |
Prescription; Discontinued |
ATC Code |
V09BA02 |
DrugBank ID |
DB09138
|
KEGG ID |
D02029
|
MeSH ID |
D013669
|
PubChem ID |
9838324
|
TTD Drug ID |
D0B4KH
|
NDC Product Code |
Not Available |
Synonyms |
Technetium Tc 99m Medronate | Tc-99 Medronate | Medronate, Tc-99 | Tc 99 Medronate | Technetium Methylene Diphosphonate | Diphosphonate, Technetium Methylene | Methylene Diphosphonate, Technetium | Technetium Tc 99m Methylenediphosphonate | 99mTc-Methylene Diphosphonate | 99mTc Methylene Diphosphonate | Diphosphonate, 99mTc-Methylene | 99mTc-MDP | Tc-99m MDP | Tc-99m Methylene Diphosphonate | Diphosphonate, Tc-99m Methylene | Methylene Diphosphonate, Tc-99m | Tc 99m Methylene Diphosphonate |
|
Chemical Information |
Molecular Formula |
CH2O6P2Tc |
CAS Registry Number |
121524-79-6 |
SMILES |
C(P(=O)([O-])[O-])P(=O)([O-])[O-].[Tc+4] |
Chemical Structure |
|
|
ADR Related Proteins Induced by Drug |
ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
Not Available | Not Available | Not Available | Not Available | Not Available |
|
ADRs Induced by Drug |
|